Stay updated on Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial
Sign up to get notified when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.

Latest updates to the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page
- Check6 days agoChange DetectedNo significant content changes were detected on the Study Details page; only minor formatting and layout adjustments observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check42 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%

- Check49 days agoChange DetectedExpanded geographic scope and clarified/increased detail in inclusion/exclusion criteria, along with new study measurements; core eligibility framework remains, but recruitment locations and data collection parameters have grown.SummaryDifference18%

- Check57 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

Stay in the know with updates to Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.